• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • BriaCell Therapeutics Corp. Announces Share Consolidation firstwordpharma
    December 24, 2019
    The Company currently has 216,589,090 Common Shares outstanding and if completed, the Consolidation would reduce the issued and outstanding Common Shares to approximately 721,924 Common Shares.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service